drugset / Trial / NCT03065075

Effect of Phenazopyridine on Prolapse Surgery Voiding Trials

NCT03065075

Phase 3 Completed 152 enrolled University of Massachusetts, Worcester
RandomizedParallel-groupOpen-labelTreatment

Summary

To determine if phenazopyridine reduces the rate of postoperative urinary retention after pelvic organ prolapse surgery.

Timeline

Start
2017-02-01
Primary completion
2018-08-28
Completion
2019-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Phenazopyridine Small molecule 200 mg Oral